Razmy, Ajmal <br/><br/>
Predictors of impaired daytime sleep and wakefulness in patients with Parkinson disease treated with older (ergot) vs newer (nonergot) dopamine agonists.  [electronic resource] 

 -  Archives of neurology  Jan 2004 
 - 97-102 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0003-9942 
<br/><br/><label>Standard No.: </label>10.1001/archneur.61.1.97  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Benzothiazoles<br/>Bromocriptine--adverse effects<br/>Disorders of Excessive Somnolence--etiology<br/>Dopamine Agonists--adverse effects<br/>Dose-Response Relationship, Drug<br/>Ergot Alkaloids--adverse effects<br/>Female<br/>Humans<br/>Indoles--adverse effects<br/>Male<br/>Middle Aged<br/>Parkinson Disease--drug therapy<br/>Pergolide--adverse effects<br/>Polysomnography<br/>Pramipexole<br/>Prospective Studies<br/>Sleep--drug effects<br/>Thiazoles--adverse effects<br/>Wakefulness--drug effects